Insights on the Facial Injectables Global Market to 2027 - by Product Type, Application Type, Application, End-user and Region
DUBLIN, Oct. 19, 2022 /PRNewswire/ -- The "Facial Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global facial injectables market size reached US$ 7.1 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 12.2 Billion by 2027, exhibiting a CAGR of 9.44% during 2021-2027.
Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Facial injectables are administered on specific areas of the face to enhance the physical appearance of the skin. These injectables are generally made using collagen, hyaluronic acid and calcium hydroxylapatite that help restore the elasticity of the skin. They are used to reduce wrinkles, augment lips, enhance shallow contours and raise depressed scars. Currently, facial injectables are gaining traction worldwide as they are safe, cost-effective and require minimal downtime.
As collagen production and formation of fat under the skin decline with age, the skin becomes more susceptible to wrinkles and sagging. This, in confluence with the growing geriatric population and the desire to retain a young and healthy skin, represents one of the key factors bolstering the market growth.
Apart from this, the escalating demand for minimally invasive surgeries, coupled with the rising trend of medical and cosmetic tourism, is contributing to the market growth. Moreover, as excessive sun exposure leads to tissue breakdown of the skin, the demand for facial injectables is escalating among outgoing individuals.
Furthermore, inflating disposable incomes, the rising influence of social media, and the growing number of professional practitioners and users willing to try organic and biodegradable materials are some of the other factors influencing the market positively. Besides this, the key players are also offering customized facial injectables to provide a personalized experience to users, which, in turn, is anticipated to create a positive outlook for the market in the coming years.
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Allergan Plc, Anika Therapeutics Inc., Bloomage BioTechnology, Johnson & Johnson, Galderma Pharma S.A., Integra LifeSciences, Ipsen (Mayroy SA), Medytox Inc., Merz Holding GmbH & Co. KG, Prollenium Medical Technologies Inc., Sanofi, SciVision Biotech Inc., Sinclair Pharma (Huadong Medicine Co. Ltd.), Suneva Medical Inc. and Bausch Health Companies Inc.
Key Questions Answered in This Report
1. What is the global facial injectables market growth?
2. What are the global facial injectables market drivers?
3. What are the key industry trends in the global facial injectables market?
4. What is the impact of COVID-19 on the global facial injectables market?
5. What is the global facial injectables market breakup by product type?
6. What is the global facial injectables market breakup by application type?
7. What is the global voltage regulators market breakup by end user?
8. What are the major regions in the global facial injectables market?
9. Who are the key companies/players in the global facial injectables market?
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Facial Injectables Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Collagen
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Hyaluronic Acid (HA)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Botulinum Toxin Type A
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Calcium Hydroxylapatite (CaHA)
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Polymethylmethacrylate Beads (PMMA Microspheres)
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Poly-L-Lactic Acid (PLLA)
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Application Type
7.1 Aesthetics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Therapeutics
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Facial Line Correction
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Lip Augmentation
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Face Lift
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Acne Scar Treatment
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Dermatology Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
11 SWOT Analysis
12 Value Chain Analysis
13 Porters Five Forces Analysis
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Allergan Plc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Anika Therapeutics Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 SWOT Analysis
15.3.3 Bloomage BioTechnology
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Johnson & Johnson
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Galderma Pharma S.A.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 SWOT Analysis
15.3.6 Integra LifeSciences
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Ipsen (Mayroy SA)
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Medytox Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Merz Holding GmbH & Co. KG
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.10 Prollenium Medical Technologies Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Sanofi
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 SciVision Biotech Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.13 Sinclair Pharma (Huadong Medicine Co. Ltd.)
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.14 Suneva Medical Inc.
15.3.14.1 Company Overview
15.3.14.2 Product Portfolio
15.3.15 Bausch Health Companies Inc.
15.3.15.1 Company Overview
15.3.15.2 Product Portfolio
15.3.15.3 Financials
15.3.15.4 SWOT Analysis
For more information about this report visit https://www.researchandmarkets.com/r/nd61kh
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article